Handayani, F. et al. 2026. Cost-Effectiveness of Anthracycline, Cyclophosphamide-Taxane (AC-T) Chemotherapy Based on Diagnostic Delay Status: A Payer Perspective. Jurnal Sains Farmasi & Klinis. 13, 02 (Aug. 2026), 168–182. DOI:https://doi.org/10.25077/jsfk.13.02.168-182.2026.